Rockley Photonics Holdings Ltd (RKLYQ)

[prototype_101]

> Biotpx healthcare biomarker sensing platform, launched two years early, which includes its wearable band, cloud analytics and AI, and product samples were shipped to multiple customers in the first quarter

> VitalSpex consumer device samples continue to ship to customers in 2022

> Timeline for the shipment of its Baseline, including core body temperature, hydration and blood pressure biomarkers, continues to be expected in the second half of 2022

> Timeline for shipment of its Pro, including alcohol, glucose and lactate, continues to be expected to ship approximately six months after its Baseline

> Rockley’s expanded customer base, which includes companies like Medtronic, has made the Company less reliant on any one customer.

Rockley Photonics (NYSE: RKLY), a global leader in photonics-based health monitoring and communications solutions, today announced that its first quarter 2022 financial results conference call has been rescheduled to after the market close on Thursday, May 12, 2022, to allow additional time to prepare its earnings report. The Company plans to host a conference call that day at 5:00 p.m. Eastern Time to review its financial results and business outlook.

“By revising our earnings date, we expect to be able to share additional information on our earnings call that we are still reviewing; for example, the preliminary results from our human study on hydration and a new product shipment milestone,” said Dr. Andrew Rickman, chairman and chief executive officer of Rockley.

https://ih.advfn.com/stock-market/NYSE/rockley-photonics-RKLY/stock-news/87908038/rockley-photonics-revises-date-of-first-quarter-20